Clinical Trials Sponsored by MorePharma Corporation

Total 6492 results

Incyte Corporation

Completed

Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)

MPN (Myeloproliferative Neoplasms)

United States
Masimo Corporation

Completed

Desaturation Validation of INVSENSOR00031

Healthy

United States
Incyte Corporation

Withdrawn

A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

Moderate to Severe Ulcerative Colitis
Incyte Corporation

Terminated

Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia

Myeloproliferative Neoplasm (MPN)

United States, Italy
Vericel Corporation

Completed

Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head (ON-CORE)

Osteonecrosis

United States
BioElectronics Corporation

Completed

Pulse Shortwave Therapy in Cervical Osteoarthritis

Cervical Osteoarthritis

Lebanon
Olympus Corporation

Terminated

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Emphysema

Japan
Pulmonx Corporation

Completed

To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves (TRANSFORM)

COPD | Heterogeneous Emphysema

Netherlands, Sweden, United Kingdom, Germany, France, Belgium
Incyte Corporation

Terminated

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Solid Tumors and Hematologic Malignancy

United States
Pulmonx Corporation

Completed

Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System (STAGE)

Emphysema

Netherlands, Germany, Austria
Incyte Corporation

No longer available

Expanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis
Incyte Corporation

No longer available

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma
Yuhan Corporation

Completed

Bioequivalence Study of Letrozole 2.5 mg Tablets

Healthy
Incyte Corporation

Completed

A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

Plaque Psoriasis

United States, Canada
Incyte Corporation

Terminated

A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Ovarian Cancer | Genitourinary (GU) Tumors

Ukraine, United Kingdom, United States, Australia, Canada, Russian Federation
Incyte Corporation

Completed

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Graft-versus-host Disease (GVHD)

United States
Incyte Corporation

Withdrawn

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Solid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)

United States
Yuhan Corporation

Completed

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Hypertension

Korea, Republic of
Yuhan Corporation

Completed

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Yuhan Corporation

Completed

A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.

Chronic Periodontitis

Korea, Republic of
Yuhan Corporation

Completed

Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers

Peripheral Neuropathic Pain

Korea, Republic of
Omeros Corporation

Completed

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Meniscal Tear

United States
Masimo Corporation

Completed

Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor

Healthy

United States
Omeros Corporation

Unknown

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Thrombotic Microangiopathies | Atypical Hemolytic Uremic Syndrome

United States
Yuhan Corporation

Completed

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

Dyslipidemia | Type II Diabetes

Korea, Republic of
Incyte Corporation

Completed

INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Rheumatoid Arthritis

United States, Czechia
Genescient Corporation

Completed

Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients

Alzheimer Disease | Alzheimer Dementia
Adimmune Corporation

Completed

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Pandemic Influenza

Taiwan
Adimmune Corporation

Completed

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

Influenza

Taiwan
Insulet Corporation

Completed

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) (IDE2)

Type 1 Diabetes Mellitus

United States
Incyte Corporation

Completed

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

HIV Infections

United States
Quidel Corporation

Completed

QuickVue Influenza A + B Test Field Study (QuickVue Flu)

Influenza A, Influenza B

United States
Incyte Corporation

Completed

COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

MPN (Myeloproliferative Neoplasms)

United States, Canada, Australia
Incyte Corporation

Completed

Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Polycythemia Vera | Thrombocytosis | Myelofibrosis

United States
Glaukos Corporation

Completed

A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.

Open-Angle Glaucoma

Germany, Spain, Turkey, Netherlands, Austria
Incyte Corporation

Terminated

Study of Ruxolitinib in Colorectal Cancer Patients

CRC (Colorectal Cancer)

United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of
Incyte Corporation

Terminated

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Carcinoma)

United States
Incyte Corporation

Terminated

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Pancreatic Cancer | Solid Tumors

United States
Incyte Corporation

Terminated

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Carcinoma)

United States
Incyte Corporation

Terminated

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

MDS (Myelodysplastic Syndrome)

United States
Glaukos Corporation

Completed

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

Open-Angle Glaucoma

United States
Glaukos Corporation

Completed

Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

Subjects With Primary Open-angle Glaucoma (POAG)

Armenia
Cerus Corporation

Completed

A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma

Healthy
Quidel Corporation

Completed

Strep A FIA Field Study, Sofia

Group A Streptococcus

United States
EPS Corporation

Completed

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases (ATOM ES)

Colorectal Cancer | Liver Metastasis

Japan
Animas Corporation

Completed

Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting

Type 1 Diabetes Mellitus

United States
Masimo Corporation

Completed

Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)

Healthy

United States
Masimo Corporation

Completed

Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor

Healthy

United States
Masimo Corporation

Completed

Accuracy of Noninvasive Hemoglobin Pulse Oximeter (Rainbow Resposable Adhesive Sensors)

Healthy

United States
Masimo Corporation

Completed

Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)

Healthy

United States

3

Subscribe